AOTI, Inc.
Status: Publicly traded
Direct answer
AOTI, Inc. is publicly traded on LSE under the ticker AOTI.L.
AOTI, Inc. specializes in creating and marketing healthcare technologies specifically designed for treating persistent and hard-to-heal wounds. Among its offerings are the innovative Topical Wound Oxygen (TWO2) Therapy and the NEXA Negative Pressure Wound Therapy (NPWT) System. Michael Stephen Griffiths founded the company in 2006, and its main office is located in Oceanside, California.
Can you invest in AOTI, Inc.?
Yes. AOTI, Inc. trades publicly on LSE as AOTI.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.